Dana (DAN) Holder Bank Of Montreal Has Cut Stake as Valuation Rose; Teva Pharmaceutical Inds LTD (TEVA) Shares Declined While Barry Investment Advisors Lowered Its Stake

January 14, 2018 - By Linda Rogers

Barry Investment Advisors Llc decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 44.38% based on its latest 2017Q3 regulatory filing with the SEC. Barry Investment Advisors Llc sold 56,063 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 70,274 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.24M, down from 126,337 at the end of the previous reported quarter. Barry Investment Advisors Llc who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be less bullish one the $22.42B market cap company. The stock increased 1.52% or $0.33 during the last trading session, reaching $22.07. About 40.56 million shares traded or 52.13% up from the average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 14, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Bank Of Montreal decreased its stake in Dana Incorporated (DAN) by 11.7% based on its latest 2017Q3 regulatory filing with the SEC. Bank Of Montreal sold 53,845 shares as the company’s stock rose 1.03% with the market. The institutional investor held 406,331 shares of the o.e.m. company at the end of 2017Q3, valued at $11.36M, down from 460,176 at the end of the previous reported quarter. Bank Of Montreal who had been investing in Dana Incorporated for a number of months, seems to be less bullish one the $5.05B market cap company. The stock increased 1.81% or $0.62 during the last trading session, reaching $34.88. About 649,217 shares traded. Dana Incorporated (NYSE:DAN) has risen 70.12% since January 14, 2017 and is uptrending. It has outperformed by 53.42% the S&P500.

Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on February, 12. They expect $0.75 EPS, down 44.85% or $0.61 from last year’s $1.36 per share. TEVA’s profit will be $762.00M for 7.36 P/E if the $0.75 EPS becomes a reality. After $0.95 actual EPS reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -21.05% negative EPS growth.

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 7 Sell and 17 Hold. Therefore 27% are positive. Teva Pharma had 127 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, May 10 by Mizuho. RBC Capital Markets maintained the stock with “Underperform” rating in Monday, September 18 report. The firm has “Hold” rating given on Wednesday, October 4 by Cowen & Co. The rating was maintained by Cantor Fitzgerald with “Hold” on Wednesday, August 30. As per Monday, November 13, the company rating was downgraded by J.P. Morgan. The firm earned “Buy” rating on Monday, December 7 by Mizuho. On Monday, November 6 the stock rating was maintained by Credit Suisse with “Underperform”. The firm earned “Market Perform” rating on Friday, August 4 by Cowen & Co. The company was maintained on Wednesday, November 16 by Maxim Group. The stock has “Buy” rating by Goldman Sachs on Monday, November 23.

Analysts await Dana Incorporated (NYSE:DAN) to report earnings on February, 8. They expect $0.54 earnings per share, down 8.47% or $0.05 from last year’s $0.59 per share. DAN’s profit will be $78.23M for 16.15 P/E if the $0.54 EPS becomes a reality. After $0.59 actual earnings per share reported by Dana Incorporated for the previous quarter, Wall Street now forecasts -8.47% negative EPS growth.

Among 10 analysts covering Dana Holding Corp (NYSE:DAN), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Dana Holding Corp had 41 analyst reports since September 28, 2015 according to SRatingsIntel. FBR Capital maintained the stock with “Outperform” rating in Friday, February 19 report. The firm earned “Equal-Weight” rating on Wednesday, August 2 by Barclays Capital. As per Friday, July 22, the company rating was maintained by RBC Capital Markets. FBR Capital downgraded Dana Incorporated (NYSE:DAN) rating on Thursday, November 10. FBR Capital has “Mkt Perform” rating and $17 target. The stock of Dana Incorporated (NYSE:DAN) has “Buy” rating given on Tuesday, October 3 by RBC Capital Markets. The firm has “Equal-Weight” rating by Barclays Capital given on Wednesday, July 19. The company was maintained on Tuesday, December 19 by RBC Capital Markets. Deutsche Bank maintained Dana Incorporated (NYSE:DAN) rating on Friday, October 23. Deutsche Bank has “Hold” rating and $18 target. The company was maintained on Friday, October 27 by Buckingham Research. The company was maintained on Friday, October 27 by Barclays Capital.

Bank Of Montreal, which manages about $34.23B and $109.19 billion US Long portfolio, upped its stake in Cara Therapeutics Inc (Put) (NASDAQ:CARA) by 25,000 shares to 34,000 shares, valued at $465,000 in 2017Q3, according to the filing. It also increased its holding in Cnooc Ltd (NYSE:CEO) by 6,833 shares in the quarter, for a total of 31,885 shares, and has risen its stake in Apple Inc (NASDAQ:AAPL).

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.05, from 1.08 in 2017Q2. It dropped, as 21 investors sold DAN shares while 83 reduced holdings. 39 funds opened positions while 68 raised stakes. 137.76 million shares or 2.31% less from 141.01 million shares in 2017Q2 were reported. Moreover, Dimensional Fund Advsrs LP has 0.05% invested in Dana Incorporated (NYSE:DAN) for 4.41 million shares. Goldman Sachs holds 3.95 million shares or 0.03% of its portfolio. Wedge Capital Mngmt L Limited Partnership Nc reported 1.47% stake. Schwab Charles Management Inc has invested 0.02% of its portfolio in Dana Incorporated (NYSE:DAN). Etrade Management Limited Liability Corp owns 0.01% invested in Dana Incorporated (NYSE:DAN) for 10,177 shares. Vident Advisory Limited Com has 0.17% invested in Dana Incorporated (NYSE:DAN) for 109,264 shares. Hsbc Holdings Public Lc invested in 83,219 shares. Barclays Public Limited Co has 6,009 shares for 0% of their portfolio. Sit Assocs Inc has invested 0% in Dana Incorporated (NYSE:DAN). Comerica Fincl Bank accumulated 0.1% or 471,624 shares. Credit Agricole S A accumulated 81,305 shares. Ajo Limited Partnership stated it has 0.56% in Dana Incorporated (NYSE:DAN). Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% in Dana Incorporated (NYSE:DAN). Invesco Ltd accumulated 4.16M shares. Voya Inv Mngmt Limited Liability Company owns 1.94M shares or 0.12% of their US portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>